Tech
United States: The United States is the primary market for the Lyme disease vaccine, with a significant and expanding incidence of the disease. Regulatory approval within the United States, particularly from the United States — Food and Drug Administration, is crucial for the vaccine's availability.
United States — Centers for Disease Control and Prevention: The United States — Centers for Disease Control and Prevention (CDC) provides crucial data on Lyme disease incidence and issues advisories regarding tick season severity, highlighting the public health need for a vaccine. The CDC's data supports the importance of the vaccine being developed by Pfizer and Valneva SE.
Apr 30, 2026 · 20 articles